tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Imunon, Inc.’s Phase II Study on IMNN-001: A Potential Game-Changer in Ovarian Cancer Treatment?
PremiumCompany AnnouncementsImunon, Inc.’s Phase II Study on IMNN-001: A Potential Game-Changer in Ovarian Cancer Treatment?
1M ago
Imunon, Inc.’s Ongoing Clinical Trial: Potential Game-Changer for Ovarian Cancer Treatment?
Premium
Company Announcements
Imunon, Inc.’s Ongoing Clinical Trial: Potential Game-Changer for Ovarian Cancer Treatment?
1M ago
Imunon, Inc. Advances Cancer Treatment with Phase 3 Trial of IMNN-001
Premium
Company Announcements
Imunon, Inc. Advances Cancer Treatment with Phase 3 Trial of IMNN-001
2M ago
IMNN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsIMNN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Imunon announces first patient dosed in Phase 3 OVATION 3 study of IMNN-001
Premium
The Fly
Imunon announces first patient dosed in Phase 3 OVATION 3 study of IMNN-001
2M ago
Imunon Announces 15% Stock Dividend Approval
Premium
Company Announcements
Imunon Announces 15% Stock Dividend Approval
2M ago
Imunon Announces Reverse Stock Split to Meet Nasdaq Rules
PremiumCompany AnnouncementsImunon Announces Reverse Stock Split to Meet Nasdaq Rules
2M ago
Imunon announces 1-for-15 reverse split ratio
Premium
The Fly
Imunon announces 1-for-15 reverse split ratio
2M ago
Imunon Registers Additional Shares to Raise Capital
Premium
Company Announcements
Imunon Registers Additional Shares to Raise Capital
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100